Compare Franklin FTSE South Korea ETF (FLKR) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $58.27 (market cap $1.83B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.5 (market cap $2.27B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is the larger of the two by market cap, and Franklin FTSE South Korea ETF is more actively traded (679,902 versus 4,179,659). Which is the better fit depends on your goals.
| FLKR | SLS | |
|---|---|---|
Market Cap | $1.83B | $2.27B |
Volume | 679,902 | 4,179,659 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $15.46 |
52-Week Low | $27.09 | $1.39 |
Typical Hold Time | 15 Days | — |
Enterprise Value | — | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
